Related Experiment Video

Updated: Jul 2, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

Apoptotic effect of CKD-602 (Camtobell) on oral squamous cell carcinoma cell lines

Yong-Ju Ok1, Hoon Myoung, Young-Kyun Kim

  • 1Department of Oral and Maxillofacial Surgery, College of Dentistry, Seoul National University, Seoul, Republic of Korea.

Oral Oncology
|August 22, 2008
PubMed

Insights

CKD-602 demonstrates significant cytotoxicity against oral squamous cell carcinoma (OSCC) cell lines, primarily inducing apoptosis. The study identified key molecular changes, including Bcl-2 down-regulation and p53 expression, in response to CKD-602 treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Oral squamous cell carcinoma (OSCC) is a significant global health concern.
  • Novel therapeutic agents are needed to improve treatment outcomes for OSCC.
  • Understanding the molecular mechanisms of cell death is crucial for developing targeted therapies.

Purpose of the Study:

  • To assess the cytotoxic effects of CKD-602 on human OSCC cell lines.
  • To determine if cell death induced by CKD-602 is apoptotic.
  • To identify signaling molecules (Bax, Bcl-2, p53) involved in CKD-602-induced apoptosis.

Main Methods:

  • Treatment of human OSCC cell lines (A253, HSC-3, KB) with CKD-602.
  • Flow cytometry analysis to quantify the apoptotic proportion of cells.
  • Western blotting to detect the expression levels of Bax, Bcl-2, and p53 proteins.

Main Results:

  • CKD-602 exhibited potent cytotoxicity against all tested OSCC cell lines.
  • The majority of cell death observed was apoptotic, not necrotic.
  • CKD-602 treatment led to Bcl-2 down-regulation in A253 and HSC-3 cells.
  • p53 expression was observed in KB cells following CKD-602 treatment.

Conclusions:

  • CKD-602 is a promising cytotoxic agent for OSCC.
  • CKD-602 effectively induces apoptosis in OSCC cells through modulation of key apoptotic proteins.
  • The differential expression of Bcl-2 and p53 suggests complex apoptotic pathways influenced by CKD-602 in different OSCC subtypes.

More Related Videos

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...